ALFA Finder| Revenue growth | Consolidated +21% YoY Q2; standalone +25% |
|---|---|
| Margins | Consol gross margin 63.8% vs 67.5%; EBITDA margin 25.1% vs 26.8% |
| Demand visibility | Customer enquiries encouraging; growth from existing portfolio |
| Management confidence | Optimistic; enquiries encouraging; no numeric guidance |
Growth
Consolidated revenue up 21% YoY to Rs123.7 cr in Q2; standalone up 25%, exports up 37%, domestic up 19%.
Outlook
No numeric guidance given. Panchla cell culture lines start H2 FY27; margin recovery expected over next two years.
Risks
Gross margin down to 63.8% from 67.5% on raw material inflation; new plants lifted depreciation and finance costs.
Last quarter's promises, checked
Delivered
- Guided ~15%+ growth → consolidated +21%, standalone +25% (= BEAT)
- Guided EBITDA margin similar to Q1's 23.6% → Q2 EBITDA margin 25.1% (= BEAT)
Partly delivered
- Guided Panchla fully commissioned in Q2, revenue from H2 → cell culture lines start H2 FY27, Q2 commissioning not confirmed (= PARTIAL)
Missed
- Guided FY27 debt cut of Rs40-50cr from ~Rs380cr gross debt → borrowings Rs387.4cr, up ~Rs7cr (= MISS)
Investor Presentation filed with BSE, NSE: TARSONS. Summary written with AI assistance from the document.
Tarsons Products Ltd: key numbers
- Share price
- ₹315.45
- Market cap
- ₹1,678 Cr
- Revenue (annual)
- ₹422.5 Cr
- Net profit (annual)
- ₹14.32 Cr
- P/E (TTM)
- 225.9×Sector 55.1×
- Promoter holding
- 47.30%+0.00% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tarsons Products Ltd
All →Tarsons Products Earnings Call Transcript: Key Takeaways
Tarsons delivered record quarterly revenue but gross margins are under severe pressure from surging crude-linked raw material costs.
Tarsons Products Q2 FY27 Results: Net Loss of ₹0.3 Cr
Tarsons Products Ltd reported revenue from operations of ₹123.7 Cr (+20.9% YoY) and a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Tarsons Products Board Meeting Date
Tarsons Products will hold a board meeting on November 12, 2026 to consider unaudited standalone and consolidated half-year results for September 2026. The trading window is closed from October 1 to November 14, 2026.
Tarsons Products Other Announcement
Tarsons Products Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Tarsons Products Management Change
Tarsons Products Limited re-appointed Sanjive Sehgal as Executive Director following his retirement by rotation. This filing updates his directorial status.
Tarsons Products Annual General Meeting
Tarsons Products Limited held its 43rd Annual General Meeting on September 24, 2026, through video conferencing. Shareholders discussed financial statements and approved various resolutions.